Pharmacology: Ondansetron is a selective 5-HT3 receptor antagonist and competitively prevent or treat nausea and vomiting associated with cytotoxic chemotherapy and radiotherapy.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
